CA
CANQF.US CanaQuest Medical Corp
- Market cap
- USD 2.12K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Dec 2024.
Is CANQF.US undervalued?
Graham numberThe Graham number of CanaQuest Medical Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CanaQuest Medical Corp fundamental analysis
No fundamental analysis for CanaQuest Medical Corp yet.
CanaQuest Medical Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CanaQuest Medical Corp
CanaQuest Medical Corp. develops health products and pharmaceuticals that utilize hemps, cannabis, and algae oils. The company was formerly known as Algae Dynamics Corp. and changed its name to CanaQuest Medical Corp. in January 2019. CanaQuest Medical Corp. was founded in 2008 and is based in Mississauga, Canada.
Full company profileCanaQuest Medical Corp financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 3 quarters up to Dec 31, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
CanaQuest Medical Corp annual financial statements
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | - | 29.2K | 1.23K | - | - | 45.9K | 52.9K |
| Gross Profit | -22.5K | -20.0K | -17.7K | 0.00 | -7.08K | 29.2K | 1.23K | -6.57K | -7.28K | 18.3K | 52.1K |
| Operating Income | -1.09M | -1.78M | -1.83M | -1.28M | -963K | -1.34M | -265K | -770K | -1.16M | -1.85M | -1.04M |
| EBITDA | -1.42M | -1.78M | -1.83M | -794K | -956K | -1.24M | -232K | -714K | -1.04M | -1.76M | -1.33M |
| Net Income | -1.09M | -1.91M | -2.59M | -1.10M | -1.11M | -1.27M | -254K | -746K | -1.13M | -1.88M | -1.43M |
| EPS | -0.12 | -0.20 | -0.23 | -0.08 | -0.06 | -0.06 | -0.01 | -0.04 | -0.05 | -0.09 | -0.07 |
| Balance Sheet | |||||||||||
| Total Assets | 142K | 109K | 92.8K | 110K | 74.9K | 67.6K | 29.1K | 87.2K | 191K | 292K | 201K |
| Total Liabilities | 894K | 809K | 897K | 948K | 810K | 780K | 846K | 945K | 1.55M | 1.79M | 1.36M |
| Shareholders' Equity | -752K | -700K | -805K | -838K | -735K | -712K | -817K | -858K | -1.36M | -1.50M | -1.16M |
| Cash & Short-term Investments | 3.08K | 173.00 | 87.00 | 8.00 | 4.16K | 595.88 | 1.89K | 20.7K | 5.54K | 105.85 | 4.82K |
| Total Debt | - | 387K | 91.4K | 154K | 152K | 151K | 252K | 432K | 859K | 510K | 153K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -252K | -210K | -342K | 27.5K | -1.09M | -48.6K | -87.3K | -238K | -660K | -371K | -75.0K |
| Capital Expenditure | 64.7K | 0.00 | 0.00 | 0.00 | 5.35 | 0.00 | 1.81K | 16.1K | 4.06K | 1.00 | 15.19 |
| Free Cash Flow | -317K | -210K | -342K | 27.5K | -1.09M | -48.6K | -89.1K | -255K | -664K | -371K | -73.1K |
| Ratios | |||||||||||
| ROA | -765.2% | -1,752.1% | -2,787.6% | -998.1% | -1,481.9% | -1,875.4% | -871.8% | -855.4% | -590.6% | -644.9% | -712.3% |
| Net Profit Margin | - | - | - | - | - | -4,332.2% | -20,681.4% | - | - | -4,093.1% | -2,709.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
CanaQuest Medical Corp dividends
CanaQuest Medical Corp has not paid dividends in the last 9 fiscal years.
Who owns CanaQuest Medical Corp
- Insiders 53.91%
- Institutions 0.00%
- Public & others 46.10%
- Shares outstanding 21.2M
- Free float 9.28M
CanaQuest Medical Corp company profile
- Company name
- CanaQuest Medical Corp
- Ticker
- CANQF.US
- ISIN
- CA1372201097
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- March
- Address
- 4120 Ridgeway Drive, Mississauga, ON, Canada, 5L5 5S9
- Phone
- 416-704-3040
- Website
- canaquest.com
About CanaQuest Medical Corp
CanaQuest Medical Corp. develops health products and pharmaceuticals that utilize hemps, cannabis, and algae oils. The company was formerly known as Algae Dynamics Corp. and changed its name to CanaQuest Medical Corp. in January 2019. CanaQuest Medical Corp. was founded in 2008 and is based in Mississauga, Canada.
CanaQuest Medical Corp management
6- Mr. Paul Ramsay BBACo-Founder, Chairman & CEO · born 1960
- Mr. Richard RusiniakCo-Founder, President, CTO & Director · born 1949
- Mr. Ross Eastley C.A.Co-Founder, CFO & Director · born 1948
- Mr. Edward FrancisInterim Chief Operating Officer
- Dr. Jordyn Stuart B.S., Ph.D.Acting Chief Scientific Officer
- Mr. Rob RindermanDirector of Communications